EUVIMEDEUVIMED entdecken
Crossref

Apoptotic vesicle-hybridized nanosponges enable dual-phase immunomodulation for targeted periodontitis therapy

Xiao-Ru Xu, Xin-Yan Luo, Lu-Fan Yang, Fei-Ran Wang, Jia-Wei Lu, Bai-Ting Luan, Yuan Yuan, Zi-Qi Zhang, Jin-Yu Liu, Yuan-Yuan Li, Yi-Han Liu, Yu Fu und 8 weitere

Chemical Engineering Journal · 2026-11 · 547 · 179975

DOI: 10.1016/j.cej.2026.179975 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Engineering Journal, 2026-11. Verfasst von Xiao-Ru Xu und 19 weiteren Autor:innen. Die Arbeit nennt 75 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Natural Science Basic Research Program of Shaanxi Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory diseases, such as periodontitis, are characterized by dysregulated immune responses and progressive tissue damage, posing significant therapeutic challenges and necessitating the development of novel, application-oriented strategies. However, achieving precise targeting of specific immune cells for immunomodulation remains challenging. In this study, we constructed an apoptotic vesicle-hybridized nanosponge system that enables dual-phase immunomodulation of macrophages in a chronic periodontitis model. This system was engineered by fusing “nanosponge” neutrophil membranes with membranes of immunomodulatory apoptotic vesicles (ApoVs) onto a mesoporous polydopamine (MPDA) core loaded with carbon monoxide (CO). Comprehensive characterization confirmed its successful fabrication and stability. Functionally, these nanosponges demonstrated a synergistic capacity to neutralize inflammatory cytokines in the extracellular milieu and, upon apoptotic signal-mediated internalization by macrophages, triggered CO release to promote macrophage polarization toward the regenerative M2 phenotype. Transcriptomic analysis further delineated the underlying mechanistic dichotomy: apoptosis-mediated anti-inflammatory reprogramming, primarily through upregulation of transforming growth factor-beta (TGF-β) signaling and downregulation of nuclear factor-kappa B (NF-κB) signaling pathways, while CO-induced metabolic regulation, involving the modulation of peroxisome proliferator-activated receptor (PPAR) signaling. Importantly, this immunomodulation functionally enhanced the osteogenic differentiation of periodontal ligament stem cells (PDLSCs) through paracrine effect. Consequently, in the rat model of periodontitis, this targeted approach effectively resolved inflammation and robustly promoted periodontal bone regeneration, without inducing observable systemic toxicity in major organs. In summary, these findings provide a proof-of-concept strategy for targeted immunomodulatory therapy in inflammatory periodontal diseases.

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Natural Science Basic Research Program of Shaanxi Province

Zitieren

APA

Xu, X., Luo, X., Yang, L., Wang, F., Lu, J., Luan, B., Yuan, Y., Zhang, Z., Liu, J., Li, Y., Liu, Y., Fu, Y., Zhang, S., Ren, L., Zheng, Y., Gong, Z., Luo, Z., Sui, B., Yuan, Z., & Zheng, C. (2026). Apoptotic vesicle-hybridized nanosponges enable dual-phase immunomodulation for targeted periodontitis therapy. Chemical Engineering Journal, 547, 179975. https://doi.org/10.1016/j.cej.2026.179975

Vancouver

Xu X, Luo X, Yang L, Wang F, Lu J, Luan B, et al. Apoptotic vesicle-hybridized nanosponges enable dual-phase immunomodulation for targeted periodontitis therapy. Chemical Engineering Journal. 2026;547:179975. doi:10.1016/j.cej.2026.179975

BibTeX
@article{Xu2026,
  author = {Xu, Xiao-Ru and Luo, Xin-Yan and Yang, Lu-Fan and Wang, Fei-Ran and Lu, Jia-Wei and Luan, Bai-Ting and Yuan, Yuan and Zhang, Zi-Qi and Liu, Jin-Yu and Li, Yuan-Yuan and Liu, Yi-Han and Fu, Yu and Zhang, Sha and Ren, Li-Heng and Zheng, Ya-Nan and Gong, Zhen and Luo, Zhuo-Jing and Sui, Bing-Dong and Yuan, Zhang and Zheng, Chen-Xi},
  title = {Apoptotic vesicle-hybridized nanosponges enable dual-phase immunomodulation for targeted periodontitis therapy},
  journal = {Chemical Engineering Journal},
  year = {2026},
  volume = {547},
  pages = {179975},
  doi = {10.1016/j.cej.2026.179975}
}
Kostenlos starten →